Literature DB >> 24508695

Cadherin 17 is a novel diagnostic marker for adenocarcinomas of the digestive system.

Nelson G Ordóñez1.   

Abstract

Cadherin 17 is a member of a multigene family of calcium-dependent, transmembrane proteins that mediates cell-cell adhesion, plays important roles during embryogenesis, and is crucial for tissue morphogenesis and maintenance. Cadherin 17 is exclusively expressed in the epithelial cells of embryonic and adult small intestine and colon, and pancreatic ducts. It has also been reported to be frequently expressed in adenocarcinomas arising in the gastrointestinal tract and pancreas. Owing to its restricted expression in these groups of tumors, cadherin 17 has proven to be a useful immunohistochemical marker for assisting in distinguishing these neoplasms from other malignancies with which they may be confused.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24508695     DOI: 10.1097/PAP.0000000000000008

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  15 in total

1.  Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type.

Authors:  Shiho Asaka; Tomoyuki Nakajima; Kaori Kugo; Risako Kashiwagi; Nozomi Yazaki; Tsutomu Miyamoto; Takeshi Uehara; Hiroyoshi Ota
Journal:  Virchows Arch       Date:  2020-01-13       Impact factor: 4.064

Review 2.  Electrochemical biosensors for measurement of colorectal cancer biomarkers.

Authors:  Wenxian Zhang; Guangchun Xiao; Jun Chen; Li Wang; Qiongzheng Hu; Jian Wu; Wenhong Zhang; Ming Song; Jinwei Qiao; Chonghai Xu
Journal:  Anal Bioanal Chem       Date:  2021-03-05       Impact factor: 4.142

3.  Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues.

Authors:  Zijie Feng; Xin He; Xuyao Zhang; Yuan Wu; Bowen Xing; Alison Knowles; Qiaonan Shan; Samuel Miller; Taylor Hojnacki; Jian Ma; Bryson W Katona; Terence P F Gade; Jörg Schrader; David C Metz; Carl H June; Xianxin Hua
Journal:  Nat Cancer       Date:  2022-03-21

Review 4.  Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer.

Authors:  W Meng; T Gu; L M Gao; Z G Zong; L Meng; Z Z Fu; L Guo
Journal:  Braz J Med Biol Res       Date:  2015-09-29       Impact factor: 2.590

5.  Integrated molecular analysis reveals complex interactions between genomic and epigenomic alterations in esophageal adenocarcinomas.

Authors:  DunFa Peng; Yan Guo; Heidi Chen; Shilin Zhao; Kay Washington; TianLing Hu; Yu Shyr; Wael El-Rifai
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

6.  Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer.

Authors:  Keisuke Matsusaka; Tetsuo Ushiku; Masayuki Urabe; Masaki Fukuyo; Hiroyuki Abe; Shumpei Ishikawa; Yasuyuki Seto; Hiroyuki Aburatani; Takao Hamakubo; Atsushi Kaneda; Masashi Fukayama
Journal:  Oncotarget       Date:  2016-09-27

Review 7.  Beyond N-Cadherin, Relevance of Cadherins 5, 6 and 17 in Cancer Progression and Metastasis.

Authors:  J Ignacio Casal; Rubén A Bartolomé
Journal:  Int J Mol Sci       Date:  2019-07-09       Impact factor: 5.923

8.  The Diagnostic Value of Cadherin 17 and CDX2 Expression as Immunohistochemical Markers in Colorectal Adenocarcinoma.

Authors:  Mariam B Abouelkhair; Shadia H Mabrouk; Sahar S A Zaki; Ola H Nada; Sarah A Hakim
Journal:  J Gastrointest Cancer       Date:  2020-09-15

Review 9.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

10.  Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma.

Authors:  Tingting Bian; Jinli Zhao; Jia Feng; Qing Zhang; Li Qian; Jian Liu; Daishan Jiang; Yifei Liu; Jianguo Zhang
Journal:  Oncotarget       Date:  2017-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.